Atlas Trials

Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B

Clinical trial NCT07709520 · RECRUITING

Trial details

NCT number
NCT07709520
Sponsor
Fujian Akeylink Biotechnology Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2026-07-10
Primary completion
2026-10-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.